Second round robin for plasma hepcidin methods: First steps toward harmonization

American Journal of Hematology

Volumn 87, Issue 10, 2012, Pages 977-983

  Kroot, Joyce J C ^a   van Herwaarden, Antonius E ^a   Tjalsma, Harold ^a   Jansen, Rob T P ^a   Hendriks, Jan C M ^a   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; RECOMBINANT HORMONE;

ARTICLE; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

ALGORITHMS; ANTIMICROBIAL CATIONIC PEPTIDES; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOCHEMISTRY; LABORATORIES; LIGANDS; MASS SPECTROMETRY; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84866746601     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23289     Document Type: Article

References (40)

1. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: Diagnostic implications. Clin Chem 2011; 57: 1650-1669.
2. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433.
3. Pietrangelo A. Hepcidin in human iron disorders: Therapeutic implications. J Hepatol 2011; 54: 173-181.
4. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-7819.
5. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044.
6. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093.
7. Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications. Clin Chem 2007; 53: 620-628.
8. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007; 110: 1048-1054.
9. Murao N, Ishigai M, Yasuno H, et al. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007; 21: 4033-4038.
10. Kobold U, Dulffer T, Dangl M, et al. Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry. Clin Chem 2008; 54: 1584-1586.
11. Bansal SS, Abbate V, Bomford A, et al. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010; 24: 1251-1259.
12. Ward DG, Roberts K, Stonelake P, et al. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Sci 2008; 6: 28.
13. Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE 2008; 3: e2706.
14. Li H, Rose MJ, Tran L, et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009; 59: 171-180.
15. Altamura S, Kiss J, Blattmann C, et al. SELDI-TOF MS detection of urinary hepcidin. Biochimie 2009; 91: 1335-1338.
16. Campostrini N, Castagna A, Zaninotto F, et al. Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol 2010; 2010: 329646.
17. Anderson DS, Kirchner M, Kellogg M, et al. Design and validation of a high-throughput matrix-assisted laser desorption ionization time-of-flight mass spectrometry method for quantification of hepcidin in human plasma. Anal Chem 2011; 83: 8357-8362.
18. Crockett DK, Kushnir MM, Phillips JD, Rockwood AL. Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25. Clin Chim Acta 2010; 411: 453-455.
19. Kroot JJC, Laarakkers CM, Geurts-Moespot AJ, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010; 56: 1570-1579.
20. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297.
21. De Domenico I, Nemeth E, Nelson JM, et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008; 8: 146-156.
22. Koliaraki V, Marinou M, Vassilakopoulos TP, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One 2009; 4: e4581.
23. Busbridge M, Griffiths C, Ashby D, et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009; 66: 150-157.
24. Grebenchtchikov N, Geurts-Moespot AJ, Kroot JJ, et al. High-sensitive radioimmunoassay for human serum hepcidin. Br J Haematol 2009; 146: 317-325.
25. Butterfield AM, Luan P, Witcher DR, et al. A Dual-Monoclonal Sandwich ELISA Specific for Hepcidin-25. Clin Chem 2010; 56: 1725-1732.
26. Kroot JJ, Kemna EH, Bansal SS, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization. Haematologica 2009; 94: 1748-1752.
27. Greg MW, Myers GL, Lou GM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011; 57: 1108-1117.
28. Schwarz P, Strnad P, von FG, et al. A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol 2011;46:648-656.
29. van Dijk BA, Kemna EH, Tjalsma H, et al. Effect of the new HJV-L165X mutation on penetrance of HFE. Blood 2007; 109: 5525-5526.
30. Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002; 277: 37597-603.
31. Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine; Approved Guideline. CLSI document C53-A. Wayne, PA: Clinical and Laboratory Standards.
32. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
33. Jordan JB, Poppe L, Haniu M, et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 2009; 284: 24155-24167.
34. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006; 52: 553-554.
35. Rej R, Jenny RW, Bretaudiere JP. Quality control in clinical chemistry: Characterization of reference materials. Talanta 1984; 31: 851-862.
36. Miller WG. Specimen materials, target values and commutability for external quality assessment (proficiency testing) schemes. Clin Chim Acta 2003; 327: 25-37.
37. Franzini C, Ceriotti F. Impact of reference materials on accuracy in clinical chemistry. Clin Biochem 1998; 31: 449-457.
38. Aschi M, Bozzi A, Di BR, Petruzzelli R. The role of disulfide bonds and N-terminus in the structural properties of hepcidins: Insights from molecular dynamics simulations. Biopolymers 2010; 93: 917-926.
39. Peslova G, Petrak J, Kuzelova K, et al. Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood 2009; 113: 6225-6236.
40. Groche D, Hoeno W, Hoss G, et al. Standardization of two immunological HbA1c routine assays according to the new IFCC reference method. Clin Lab 2003; 49: 657-661.